Managers / Q4 2025 · view latest →
Gildi - lifeyrissjodur
CIK 0002108148 · GUDRUNARTUN 1, REYKJAVIK, 105 · 003545154700
Summary
Gildi - Lifeyrissjodur reported $221M in U.S.-listed holdings across 2 positions for Q4 2025.
The portfolio is heavily concentrated: JBTM alone accounts for 77.3% of reported value.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 77.3% · $171M
- Other · 22.7% · $50M
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| JBTMJBT MAREL CORPORATION | NEW | +1.11M | 1.11M | +$171M | $171M |
| OCULIS HOLDING AG | NEW | +2.45M | 2.45M | +$50M | $50M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | JBTMJBT MAREL CORPORATIONhistory → | COM | 77.27% | $171M | 1.11M |
| 2 | OCULIS HOLDING AG | ORDINARY SHARES | 22.73% | $50M | 2.45M |
Filing History
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.